Mitochondrial Carrier SLC25A13 Drives Ferroptosis Resistance and Immune Evasion via a STAT3–IFI6 Circuit in Breast Cancer
Yingze Zhu, Yuhan Tang, Yingcui Chen, Zhuoqi Zhang, Yige Lu, Xinyue Wang, Qiyuan Shi, Wenhui Zhao, Hui Pang · 2026
Read Mitochondrial Carrier SLC25A13 Drives Ferroptosis Resistance and Immune Evasion via a STAT3–IFI6 Circuit in Breast Cancer by Yingze Zhu, Yuhan Tang, Yingcui Chen, Zhuoqi Zhang, Yige Lu, Xinyue Wang, Qiyuan Shi, Wenhui Zhao, Hui Pang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13336081.txt.
Description
Yingze Zhu and colleagues study 2026 mitochondrial carrier SLC25A13 driving iron death resistance and immune evasion via a STAT3-IFI6 circuit in breast cancer. Triple-negative breast cancer remains poorly responsive to immune therapy, and how iron death can be used to boost anti-tumor immunity is unclear. The authors name SLC25A13, a mitochondrial aspartate/glutamate carrier, as a central immunometabolic driver in triple-negative breast cancer.
Functionally, SLC25A13 promotes tumor growth, migration, and spread while suppressing iron death and weakening CD8-positive T-cell-mediated killing power. In detail, SLC25A13 links with STAT3, lifts complex I-linked oxidative phosphorylation, holds back mitochondrial ROS, and spurs STAT3 switching on and nuclear movement. Nuclear STAT3 switches on IFI6 at once, which keeps mitochondrial function intact, curbs lipid peroxidation and iron buildup, and thereby confers iron death resistance and immune evasion.
Catalog record
| CREATOR | Yingze Zhu, Yuhan Tang, Yingcui Chen, Zhuoqi Zhang, Yige Lu, Xinyue Wang, Qiyuan Shi, Wenhui Zhao, Hui Pang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 112 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |